NCT00074269 2023-06-05
Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer
University of California, San Diego
Phase 2 Terminated
University of California, San Diego
Dana-Farber Cancer Institute
ETOP IBCSG Partners Foundation
University of California, San Francisco
University of Washington
HaEmek Medical Center, Israel